HopeStage
Back to all studies
CompletedNCT05591703

Long-term outcomes after ear nerve stimulation for opioid relapse prevention

About this titleRead the official source — NCT05591703
Observational studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Rancho Mirage and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 21, 2022
Recruitment status
Completed
Enrollment listed in the registry
32
Sponsor
Spark Biomedical, Inc.
Sponsor type
Other organization
Study type
Observational
Intervention type
Behavioural
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05591703
Official title
Show the full official title

Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Rancho Mirage · Center City · Plymouth

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Spark Biomedical, Inc.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies